NASDAQ
Aurinia Pharmaceuticals Inc. (AUPH) has a current ratio of 5.25x as of Tuesday, May 26, 2026. This represents a 34.99% decrease compared to its 12-month average of 8.07x. The current ratio measures a company's ability to cover short-term obligations by comparing current assets to current liabilities.
No price data available for this timeframe.